STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1
Author(s) -
Toufeng Jin
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i5.703
Subject(s) - stromal cell , gist , microbiology and biotechnology , viability assay , mtt assay , cancer research , vascular endothelial growth factor , flow cytometry , stem cell factor , cell culture , biology , cell growth , imatinib mesylate , vascular endothelial growth factor a , chemistry , imatinib , stem cell , vegf receptors , haematopoiesis , biochemistry , myeloid leukemia , genetics
To estimate whether STI571 inhibits the expression of vascular endothelial growth factor (VEGF) in the gastrointestinal stromal tumor (GIST) cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom